期刊文献+

急性心肌梗死患者经皮冠状动脉介入治疗后尿水通道蛋白-2的变化及意义 被引量:3

Change and significance of urinary aquaporin-2 in patients with acute myocardial infarction after percutaneous coronary intervention
下载PDF
导出
摘要 目的研究急性心肌梗死经皮冠状动脉介入(percutaneous coronary intervention,PCI)治疗后尿水通道蛋白-2(aquaporin-2,AQP2)的变化,探讨AQP2与心肌细胞水肿的关系。方法选择80例急性心肌梗死患者,分组检验治疗前、后尿AQP2不同时段浓度,同时检测血清肌钙蛋白-I、B型脑钠肽浓度。分析AQP2与肌钙蛋白-I、B型脑钠肽的相关性。结果心肌梗死组尿AQP2浓度明显高于正常对照组,差异有统计学意义(P<0.05)。早期再灌注治疗能显著降低尿AQP2浓度,差异有统计学意义(P<0.01)。急诊PCI治疗亚组较尿激酶亚组更能降低尿AQP2浓度,差异有统计学意义(P<0.05)。心肌梗死后血清肌钙蛋白-I(r=0.89,P<0.03)、B型脑钠肽浓度(r=0.78,P<0.05)与AQP2显著正相关。结论急性心肌梗死后尿AQP2浓度明显升高,PCI治疗能显著降低尿AQP2浓度。AQP2与心肌坏死指标和心力衰竭指标相关性高,可能参与急性心肌梗死后心力衰竭的发生、发展。 Objectives To research the change and significance of urinary aquaporin-2 (AQP2) in patients with acute myocardial infarction after percutaneous coronary intervention (PCI), and to study the relation between AQP2 and cellular edema. Methods We selected 80 patients with acute myocardial infarction in this study. The patients were divided into different groups and urine concentrations of AQP2 in different periods before and after treatment were tested. Serum concentrations of troponin-I and brain natriuretic peptide (BNP) were also tested. Correlation analysis was carried out on AQP2 ,troponin-I and BNP. Results Urine concentration of AQP2 in patients with acute myocardial infarction was obviously higher than that in control group (P〈0.05). Urine concentration of AQP2 significantly reduced after early reperfusion treatment (P〈0.01). Urine concentration of AQP2 reduced much more in PCI subgroup than in urokinase subgroup (P〈0.05). Serum concentrations of troponin-I (r=0.89, P〈0.03) and BNP (r=0.78, P〈0.05) after acute myocardial infarction had positive relations with AQP2. Conclusions Urine concentration of AQP2 increases in patients with acute myocardial infarction, and it reduces after PCI. AQP2 has a high relation with myocardial necrosis and heart failure index, and it may affect the occurrence and development of acute heart failure after myocardial infarction.
出处 《岭南心血管病杂志》 2013年第6期695-697,共3页 South China Journal of Cardiovascular Diseases
基金 2013年韶关卫生局课题(项目编号:Y13138)
关键词 急性心肌梗死 水通道蛋白-2 肌钙蛋白-I B型脑钠肽 acute myocardial infarction aquaporin-2 troponin-I brain natriuretic peptide
  • 相关文献

参考文献7

  • 1GHUGRE N R, RAMANAN V, POP M, et al. Quantitative tracking of edema, hemorrhage, and microvascular obstruction in subacute myocardial infarction in a porcine model by MRI [ J ]. Magn Reson Med, 2011, 66(4) : 1129-1141.
  • 2MONMENEU J V, BODI V, SANCHIS J, et al. Cardiac magnetic resonance evaluation of edema after ST-elevation acute myocardial infarction[J]. Rev Esp Cardiol, 2009, 62(8) : 858-866.
  • 3HERA CHIKUMA M,VERKMAN A S. Physiological roles of glycerol-transporting aquqporin: the aquaglyceroporin [J]. Cell Mol Life Sci, 2006, 63(12) : 1386-1392.
  • 4WEN H, FROKIAER J, KWON T H, et al. Urinary ercretion of aquaporin-2 in rat is mediated by a vasopressin-dependent apical pathway[J]. J Am Soc Nephrol, 1999, 10(7) : 1416-1429.
  • 5BUTLER T L, AU C G, YANG B, et al. Cardiac aquaporin expression in huma, rats, and mice [J ]. Am J Physiol Heart Circ Phvsiol. 2004. 291(2):705-713.
  • 6殷晓艳,许顶立,邓英姿,卢武生.心肌梗塞致心力衰竭大鼠模型不同时期尿液水通道蛋白-2的改变[J].中国病理生理杂志,2000,16(8):690-693. 被引量:9
  • 7杨明,宋建平,谢桥涛,刘艳宾,李红霞.充血性心力衰竭患者尿水通道蛋白2的变化[J].江苏医药,2008,34(10):993-994. 被引量:5

二级参考文献8

共引文献11

同被引文献20

  • 1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2125
  • 2Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care [J]. Eur Heart J,2010,31(18) :2197-2204.
  • 3Morgenthaler NG, Struck J, Alonso C, et al. Assay for the inassurement of copeptin.A stable peptide derived from the precursor of vasopressin [J]. Clin Chem,2006,52 (1) : 112- 119.
  • 4Katan M, Morgenthaler N, Widmer I,et al.Copeptin,a stable peptide derived from the vasopress in precursor, correlates with the individual stress level [J]. Neum Endocrinol Lett, 2008,29 (3) : 341-346.
  • 5Nickel CH, Bingisser R, Morgenthaler NG, et al. The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department [J ]. BMC Med, 2012, 10 (8) : 1741-1745.
  • 6Morgenthaler NG. Copeptin: a biomarker of cardiovascular and renal function [J]. Congest Heart Fail,2010, 16 Suppl 1 :$37- 44.
  • 7Khan SQ, Dhillon OS, Quinn PA, et al. C-terminal provasopressin (copeptin)as a novel and prognostic marker in acute myocardial infarction : Leicester Acute MyocardialInfarction Peptide (LAMP) study [J]. Circulation,2007,115 (16) :2103- 2110.
  • 8Charpentier S, Maupas-Schwalm F, Coumot M, et al.Combination of copeptin and troponin assays to rapidly rule out non-ST elevation myocardial infarction in the emergency department [J]. Acad Emerg Med, 2012,19 (5) : 517-524.
  • 9Ray P, Charpentier S, Chenevier-Gob C, et al. Combined copeptin and troponin to rule out myocardial infarction in patients with chest pain and a history of coronary artery disease [J]. Am J Emerg Med, 2012,30(3) :440-448.
  • 10王晓艳,杨侃,孙明,党瑜华.急性心肌梗死患者BNP和Copeptin水平变化及临床意义[J].中国现代医学杂志,2009,19(11):1699-1701. 被引量:11

引证文献3

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部